Pharmacy, Pharmaceutical Sciences, and Administration at Concordia University-Wisconsin

A debt-to-earnings ratio of 0.49 suggests manageable financial positioning, but the uncertainty here runs deeper than usual estimation challenges. With just two schools offering pharmacy-related bachelor's programs in Wisconsin and no comparable in-state programs reporting actual outcomes, we're flying blind on what this credential typically delivers in the region. The estimated $49,444 first-year earnings figure comes from national medians across pharmaceutical sciences programs, which can range from pre-pharmacy pathways to pharmaceutical marketing tracks—vastly different career trajectories with different earning potential.

The $24,000 estimated debt load sits near the national benchmark for these programs, which is reassuring on its face. But here's the complication: many students pursuing pharmaceutical sciences at the bachelor's level continue to pharmacy school (PharmD), making this degree a stepping stone rather than a terminal credential. If your child plans to stop at the bachelor's level, you need clarity on whether Concordia's specific program focuses on direct-entry careers like pharmaceutical sales, regulatory affairs, or lab work—and what those local job markets actually pay new graduates.

Before committing, demand concrete placement data from the school itself: where do their pharmacy science bachelor's graduates actually work, and what do they earn? Without reported outcomes for this program, you're essentially betting on Concordia's reputation and network in Wisconsin's pharmaceutical sector. If your child is pharmacy-school-bound, evaluate this as part of a longer educational investment; if not, you need more evidence that this bachelor's alone opens doors worth the cost.